Author Archives: Hank

Endo, Biogen lead drug stocks north BOSTON (MarketWatch) — Endo Pharmaceuticals Holdings Inc. and Biogen Idec Inc. helped lead drug stocks north Monday, as the broader market also moved into positive territory. Shares of Endo (ENDP 41.34, +0.49, +1.20%) jumped … Continue reading →

SuperGen To Acquire Astex Pharmaceutical company SuperGen Inc, released a statement on Thursday stating the company has agreed to purchasing British based drug company Astex Therapeutics Ltd. SuperGen’s released partial terms of the deal stating that they will be acquiring … Continue reading →

Questions raised about industry influence on anti-depressant studies For more than two decades, researchers have been unable to settle an important question: Can anti-depressant medications stimulate the growth of breast and ovarian cancers? Some studies pointed to a link, but … Continue reading →

Merck Sees Inspiration in Eye Care Mergers and acquisitions continue in the pharma sector with Merck (MRK – Analyst Report) recently announcing its intention to acquire specialty pharma company Inspire Pharmaceuticals, Inc. (ISPH – Snapshot Report). The companies have entered … Continue reading →

New drugs from bugs Scientists from the Universities of Bristol and Birmingham have discovered how marine bacteria join together two antibiotics they make independently to produce a potent chemical that can kill drug-resistant strains of the MRSA superbug. Working with … Continue reading →

Rexahn Pharmaceuticals to Present at Needham & Company’s 10th Annual Healthcare Conference Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present at Needham … Continue reading →

Procter & Gamble (NYSE:PG) Expands With Teva According to Cincinatti.com, Consumer products company Procter & Gamble (NYSE:PG) announced that it will make a partnership agreement with Israeli pharmaceuticals firm Teva Pharmaceutical Ltd. to promote growth in its over-the-counter drug business … Continue reading →

Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer THE WOODLANDS, Texas, March 24, 2011 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that Pablo Lapuerta, M.D. has … Continue reading →

NHS could publish prescription details for every GP practice Information on the 900million medicine prescriptions written out each year by England’s doctors, currently only seen by certain NHS staff, could be made available to the public online. A little-noticed section … Continue reading →

Research and Markets: 2011 Global Contract Manufacturing Market Analysis The global pharmaceutical contract manufacturing industry has registered strong growth during the past few years. The outsourcing of drugs manufacturing provides many advantages to the pharmaceutical companies, such as improved production … Continue reading →